img

Global Finasteride Oral Tablet Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Finasteride Oral Tablet Market Research Report 2024

Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
According to Mr Accuracy reports new survey, global Finasteride Oral Tablet market is projected to reach US$ 1283.9 million in 2029, increasing from US$ 672.9 million in 2022, with the CAGR of 8.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Oral Tablet market research.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Finasteride Oral Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
Segment by Type
1mg Tablet
5mg Tablet

Segment by Application


Benign Prostatic Hyperplasia
Male Pattern Baldness
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Finasteride Oral Tablet report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Finasteride Oral Tablet Market Overview
1.1 Product Overview and Scope of Finasteride Oral Tablet
1.2 Finasteride Oral Tablet Segment by Type
1.2.1 Global Finasteride Oral Tablet Market Value Comparison by Type (2024-2034)
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Finasteride Oral Tablet Segment by Application
1.3.1 Global Finasteride Oral Tablet Market Value by Application: (2024-2034)
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Global Finasteride Oral Tablet Market Size Estimates and Forecasts
1.4.1 Global Finasteride Oral Tablet Revenue 2018-2029
1.4.2 Global Finasteride Oral Tablet Sales 2018-2029
1.4.3 Global Finasteride Oral Tablet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Finasteride Oral Tablet Market Competition by Manufacturers
2.1 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2018-2024)
2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Finasteride Oral Tablet Average Price by Manufacturers (2018-2024)
2.4 Global Finasteride Oral Tablet Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Finasteride Oral Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride Oral Tablet, Product Type & Application
2.7 Finasteride Oral Tablet Market Competitive Situation and Trends
2.7.1 Finasteride Oral Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Finasteride Oral Tablet Players Market Share by Revenue
2.7.3 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Oral Tablet Retrospective Market Scenario by Region
3.1 Global Finasteride Oral Tablet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Finasteride Oral Tablet Global Finasteride Oral Tablet Sales by Region: 2018-2029
3.2.1 Global Finasteride Oral Tablet Sales by Region: 2018-2024
3.2.2 Global Finasteride Oral Tablet Sales by Region: 2024-2029
3.3 Global Finasteride Oral Tablet Global Finasteride Oral Tablet Revenue by Region: 2018-2029
3.3.1 Global Finasteride Oral Tablet Revenue by Region: 2018-2024
3.3.2 Global Finasteride Oral Tablet Revenue by Region: 2024-2029
3.4 North America Finasteride Oral Tablet Market Facts & Figures by Country
3.4.1 North America Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Finasteride Oral Tablet Sales by Country (2018-2029)
3.4.3 North America Finasteride Oral Tablet Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Finasteride Oral Tablet Market Facts & Figures by Country
3.5.1 Europe Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Finasteride Oral Tablet Sales by Country (2018-2029)
3.5.3 Europe Finasteride Oral Tablet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Oral Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Finasteride Oral Tablet Sales by Country (2018-2029)
3.6.3 Asia Pacific Finasteride Oral Tablet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Finasteride Oral Tablet Market Facts & Figures by Country
3.7.1 Latin America Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Finasteride Oral Tablet Sales by Country (2018-2029)
3.7.3 Latin America Finasteride Oral Tablet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride Oral Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Finasteride Oral Tablet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Finasteride Oral Tablet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Finasteride Oral Tablet Sales by Type (2018-2029)
4.1.1 Global Finasteride Oral Tablet Sales by Type (2018-2024)
4.1.2 Global Finasteride Oral Tablet Sales by Type (2024-2029)
4.1.3 Global Finasteride Oral Tablet Sales Market Share by Type (2018-2029)
4.2 Global Finasteride Oral Tablet Revenue by Type (2018-2029)
4.2.1 Global Finasteride Oral Tablet Revenue by Type (2018-2024)
4.2.2 Global Finasteride Oral Tablet Revenue by Type (2024-2029)
4.2.3 Global Finasteride Oral Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Finasteride Oral Tablet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Finasteride Oral Tablet Sales by Application (2018-2029)
5.1.1 Global Finasteride Oral Tablet Sales by Application (2018-2024)
5.1.2 Global Finasteride Oral Tablet Sales by Application (2024-2029)
5.1.3 Global Finasteride Oral Tablet Sales Market Share by Application (2018-2029)
5.2 Global Finasteride Oral Tablet Revenue by Application (2018-2029)
5.2.1 Global Finasteride Oral Tablet Revenue by Application (2018-2024)
5.2.2 Global Finasteride Oral Tablet Revenue by Application (2024-2029)
5.2.3 Global Finasteride Oral Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Finasteride Oral Tablet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Finasteride Oral Tablet Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Accord Healthcare UK
6.2.1 Accord Healthcare UK Corporation Information
6.2.2 Accord Healthcare UK Description and Business Overview
6.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Portfolio
6.2.5 Accord Healthcare UK Recent Developments/Updates
6.3 Relonchem
6.3.1 Relonchem Corporation Information
6.3.2 Relonchem Description and Business Overview
6.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Relonchem Finasteride Oral Tablet Product Portfolio
6.3.5 Relonchem Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sandoz Finasteride Oral Tablet Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Teva Generics
6.5.1 Teva Generics Corporation Information
6.5.2 Teva Generics Description and Business Overview
6.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Teva Generics Finasteride Oral Tablet Product Portfolio
6.5.5 Teva Generics Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Cipla Finasteride Oral Tablet Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Dr. Reddy
6.6.1 Dr. Reddy Corporation Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Dr. Reddy Finasteride Oral Tablet Product Portfolio
6.7.5 Dr. Reddy Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 Henan Topfond
6.9.1 Henan Topfond Corporation Information
6.9.2 Henan Topfond Description and Business Overview
6.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Henan Topfond Finasteride Oral Tablet Product Portfolio
6.9.5 Henan Topfond Recent Developments/Updates
6.10 Zhejiang CONBA Pharmaceutical
6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Portfolio
6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.11 Shandong Renhetang Pharmaceutical
6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
6.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Description and Business Overview
6.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Portfolio
6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.12 Guangdong Eashu Pharmacetical
6.12.1 Guangdong Eashu Pharmacetical Corporation Information
6.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Description and Business Overview
6.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Portfolio
6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
6.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
6.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
6.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Description and Business Overview
6.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Portfolio
6.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Oral Tablet Industry Chain Analysis
7.2 Finasteride Oral Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Oral Tablet Production Mode & Process
7.4 Finasteride Oral Tablet Sales and Marketing
7.4.1 Finasteride Oral Tablet Sales Channels
7.4.2 Finasteride Oral Tablet Distributors
7.5 Finasteride Oral Tablet Customers
8 Finasteride Oral Tablet Market Dynamics
8.1 Finasteride Oral Tablet Industry Trends
8.2 Finasteride Oral Tablet Market Drivers
8.3 Finasteride Oral Tablet Market Challenges
8.4 Finasteride Oral Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Finasteride Oral Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Finasteride Oral Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Finasteride Oral Tablet Market Competitive Situation by Manufacturers in 2022
Table 4. Global Finasteride Oral Tablet Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Finasteride Oral Tablet Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Finasteride Oral Tablet Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Finasteride Oral Tablet Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Finasteride Oral Tablet, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Finasteride Oral Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Finasteride Oral Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Finasteride Oral Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Finasteride Oral Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride Oral Tablet as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Finasteride Oral Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Finasteride Oral Tablet Sales by Region (2018-2024) & (K Units)
Table 18. Global Finasteride Oral Tablet Sales Market Share by Region (2018-2024)
Table 19. Global Finasteride Oral Tablet Sales by Region (2024-2029) & (K Units)
Table 20. Global Finasteride Oral Tablet Sales Market Share by Region (2024-2029)
Table 21. Global Finasteride Oral Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Finasteride Oral Tablet Revenue Market Share by Region (2018-2024)
Table 23. Global Finasteride Oral Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Finasteride Oral Tablet Revenue Market Share by Region (2024-2029)
Table 25. North America Finasteride Oral Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Finasteride Oral Tablet Sales by Country (2018-2024) & (K Units)
Table 27. North America Finasteride Oral Tablet Sales by Country (2024-2029) & (K Units)
Table 28. North America Finasteride Oral Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Finasteride Oral Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Finasteride Oral Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Finasteride Oral Tablet Sales by Country (2018-2024) & (K Units)
Table 32. Europe Finasteride Oral Tablet Sales by Country (2024-2029) & (K Units)
Table 33. Europe Finasteride Oral Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Finasteride Oral Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Finasteride Oral Tablet Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Finasteride Oral Tablet Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Finasteride Oral Tablet Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Finasteride Oral Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Finasteride Oral Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Finasteride Oral Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Finasteride Oral Tablet Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Finasteride Oral Tablet Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Finasteride Oral Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Finasteride Oral Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Finasteride Oral Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Finasteride Oral Tablet Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Finasteride Oral Tablet Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Finasteride Oral Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Finasteride Oral Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Finasteride Oral Tablet Sales (K Units) by Type (2018-2024)
Table 51. Global Finasteride Oral Tablet Sales (K Units) by Type (2024-2029)
Table 52. Global Finasteride Oral Tablet Sales Market Share by Type (2018-2024)
Table 53. Global Finasteride Oral Tablet Sales Market Share by Type (2024-2029)
Table 54. Global Finasteride Oral Tablet Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Finasteride Oral Tablet Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Finasteride Oral Tablet Revenue Market Share by Type (2018-2024)
Table 57. Global Finasteride Oral Tablet Revenue Market Share by Type (2024-2029)
Table 58. Global Finasteride Oral Tablet Price (US$/Unit) by Type (2018-2024)
Table 59. Global Finasteride Oral Tablet Price (US$/Unit) by Type (2024-2029)
Table 60. Global Finasteride Oral Tablet Sales (K Units) by Application (2018-2024)
Table 61. Global Finasteride Oral Tablet Sales (K Units) by Application (2024-2029)
Table 62. Global Finasteride Oral Tablet Sales Market Share by Application (2018-2024)
Table 63. Global Finasteride Oral Tablet Sales Market Share by Application (2024-2029)
Table 64. Global Finasteride Oral Tablet Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Finasteride Oral Tablet Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Finasteride Oral Tablet Revenue Market Share by Application (2018-2024)
Table 67. Global Finasteride Oral Tablet Revenue Market Share by Application (2024-2029)
Table 68. Global Finasteride Oral Tablet Price (US$/Unit) by Application (2018-2024)
Table 69. Global Finasteride Oral Tablet Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck Finasteride Oral Tablet Product
Table 74. Merck Recent Developments/Updates
Table 75. Accord Healthcare UK Corporation Information
Table 76. Accord Healthcare UK Description and Business Overview
Table 77. Accord Healthcare UK Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Accord Healthcare UK Finasteride Oral Tablet Product
Table 79. Accord Healthcare UK Recent Developments/Updates
Table 80. Relonchem Corporation Information
Table 81. Relonchem Description and Business Overview
Table 82. Relonchem Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Relonchem Finasteride Oral Tablet Product
Table 84. Relonchem Recent Developments/Updates
Table 85. Sandoz Corporation Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Sandoz Finasteride Oral Tablet Product
Table 89. Sandoz Recent Developments/Updates
Table 90. Teva Generics Corporation Information
Table 91. Teva Generics Description and Business Overview
Table 92. Teva Generics Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Teva Generics Finasteride Oral Tablet Product
Table 94. Teva Generics Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Cipla Finasteride Oral Tablet Product
Table 99. Cipla Recent Developments/Updates
Table 100. Dr. Reddy Corporation Information
Table 101. Dr. Reddy Description and Business Overview
Table 102. Dr. Reddy Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Dr. Reddy Finasteride Oral Tablet Product
Table 104. Dr. Reddy Recent Developments/Updates
Table 105. Aurobindo Pharma Corporation Information
Table 106. Aurobindo Pharma Description and Business Overview
Table 107. Aurobindo Pharma Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Aurobindo Pharma Finasteride Oral Tablet Product
Table 109. Aurobindo Pharma Recent Developments/Updates
Table 110. Henan Topfond Corporation Information
Table 111. Henan Topfond Description and Business Overview
Table 112. Henan Topfond Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Henan Topfond Finasteride Oral Tablet Product
Table 114. Henan Topfond Recent Developments/Updates
Table 115. Zhejiang CONBA Pharmaceutical Corporation Information
Table 116. Zhejiang CONBA Pharmaceutical Description and Business Overview
Table 117. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product
Table 119. Zhejiang CONBA Pharmaceutical Recent Developments/Updates
Table 120. Shandong Renhetang Pharmaceutical Corporation Information
Table 121. Shandong Renhetang Pharmaceutical Description and Business Overview
Table 122. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product
Table 124. Shandong Renhetang Pharmaceutical Recent Developments/Updates
Table 125. Guangdong Eashu Pharmacetical Corporation Information
Table 126. Guangdong Eashu Pharmacetical Description and Business Overview
Table 127. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product
Table 129. Guangdong Eashu Pharmacetical Recent Developments/Updates
Table 130. Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
Table 131. Shanghai Shyndec Pharmaceutical Co.,Ltd. Description and Business Overview
Table 132. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product
Table 134. Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Finasteride Oral Tablet Distributors List
Table 138. Finasteride Oral Tablet Customers List
Table 139. Finasteride Oral Tablet Market Trends
Table 140. Finasteride Oral Tablet Market Drivers
Table 141. Finasteride Oral Tablet Market Challenges
Table 142. Finasteride Oral Tablet Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Finasteride Oral Tablet
Figure 2. Global Finasteride Oral Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Finasteride Oral Tablet Market Share by Type in 2022 & 2029
Figure 4. 1mg Tablet Product Picture
Figure 5. 5mg Tablet Product Picture
Figure 6. Global Finasteride Oral Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Finasteride Oral Tablet Market Share by Application in 2022 & 2029
Figure 8. Benign Prostatic Hyperplasia
Figure 9. Male Pattern Baldness
Figure 10. Others
Figure 11. Global Finasteride Oral Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Finasteride Oral Tablet Market Size (2018-2029) & (US$ Million)
Figure 13. Global Finasteride Oral Tablet Sales (2018-2029) & (K Units)
Figure 14. Global Finasteride Oral Tablet Average Price (US$/Unit) & (2018-2029)
Figure 15. Finasteride Oral Tablet Report Years Considered
Figure 16. Finasteride Oral Tablet Sales Share by Manufacturers in 2022
Figure 17. Global Finasteride Oral Tablet Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Finasteride Oral Tablet Players: Market Share by Revenue in 2022
Figure 19. Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Finasteride Oral Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Finasteride Oral Tablet Sales Market Share by Country (2018-2029)
Figure 22. North America Finasteride Oral Tablet Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Finasteride Oral Tablet Sales Market Share by Country (2018-2029)
Figure 26. Europe Finasteride Oral Tablet Revenue Market Share by Country (2018-2029)
Figure 27. Germany Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Finasteride Oral Tablet Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Finasteride Oral Tablet Revenue Market Share by Region (2018-2029)
Figure 34. China Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Finasteride Oral Tablet Sales Market Share by Country (2018-2029)
Figure 45. Latin America Finasteride Oral Tablet Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Finasteride Oral Tablet Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Finasteride Oral Tablet Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Finasteride Oral Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Finasteride Oral Tablet by Type (2018-2029)
Figure 55. Global Revenue Market Share of Finasteride Oral Tablet by Type (2018-2029)
Figure 56. Global Finasteride Oral Tablet Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Finasteride Oral Tablet by Application (2018-2029)
Figure 58. Global Revenue Market Share of Finasteride Oral Tablet by Application (2018-2029)
Figure 59. Global Finasteride Oral Tablet Price (US$/Unit) by Application (2018-2029)
Figure 60. Finasteride Oral Tablet Value Chain
Figure 61. Finasteride Oral Tablet Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed